Reversal of neuromuscular blockade with sugammadex or neostigmine/atropine: Effect on postoperative gastrointestinal motility
- J Clin Anesth. 2016 Aug:32:208-13. doi: 10.1016/j.jclinane.2016.03.010.
- 1. Recep Tayyip Erdogan University, Medical Faculty, Department of Anaesthesiology and Reanimation, Rize, Turkey.
- 2. Recep Tayyip Erdogan University, Medical Faculty, Department of Anaesthesiology and Reanimation, Rize, Turkey. Electronic address: [email protected].
- 3. Sakarya University, Medical Faculty, Anaesthesiology and Reanimation, Sakarya, Turkey.
- 4. Recep Tayyip Erdogan University, Medical Faculty, Department of General Surgery, Rize, Turkey.
Study objective: To compare sugammadex with conventional reversal of neuromuscular block in terms of postoperative gastrointestinal motility.
Design: Double blinded, randomized, controlled clinical trial.
Setting: Operating room, postoperative recovery area.
Patients: Seventy-two patients with ASA physical status I or II, scheduled for total thyroid surgery were studied.
Interventions: When 4 twitches were observed on train-of-four stimulation, neuromuscular block was reversed conversatively in the control group, and with sugammadex in the study group.
Measurements: Time to first flatus and feces, incidence of postoperative nausea, vomiting, diarrhea and constipation were collected.
Main results: Median time of first flatus was 24 hours (18-32 [10-36]) in the neostigmine group, and 24 (18-28 [12-48]) in the sugammadex group (P > .05). Median (IQR) time of first feces was 24 hours (18-36 [10-48]) in neostigmine group, 32 hours (28-36 [12-72]) in sugammadex group (P > .05). There were no occurrences of nausea, vomiting, diarrhea, or constipation.
Conclusions: Sugammadex may be safely used in cases where postoperative ileus is expected.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Endogenous MetaboliteResearch Areas: Neurological Disease